The Ritz-Carlton, Laguna Niguel
1 Ritz-Carlton Drive
Dana Point, CA
As the organizers of the Phoenix Conference, we take a great deal of pride in our annual event, which has long provided medical device and diagnostic executives with an unrivaled experience that helps to inform and shape company strategy for the years ahead.
At the same time, our top priority is the health and safety of everyone involved in our program. As a result, in light of the current COVID-19 pandemic, current conditions require us to cancel the 27th Annual Phoenix Conference, which was scheduled to take place at the Ritz-Carlton, Laguna Niguel, on October 7-9, 2020.
The cancellation of this year's event is not the outcome we had hoped for, but given our concern for your well-being, current social distancing restrictions, and our commitment to contributing to global, national, and local efforts to slow the spread of the virus, we believe this is the right decision.
We wish you and yours continued good health, and look forward to seeing you at next year's Phoenix Conference.
Norilyn Ingram
ningram@wsgr.comCasey represented innovative companies in the medical devices industry.
Elton specializes in public and private corporate finance and corporate law and governance. He also has considerable M&A and venture capital experience.
Philip focuses primarily on the representation of medical device, biotechnology, pharmaceutical, diagnostic, and digital health companies in corporate governance, IPO, M&A, public company reporting, and private equity and debt financing matters.
Scott advises clients in a broad range of corporate transactions and related matters.
James advises life sciences and tech companies on a wide variety of matters and has extensive experience working with venture capital firms and other investors in private equity and debt financings.
James is a veteran attorney focused on helping medical device companies protect and enforce their domestic and international intellectual property rights.
David represents pharmaceutical, biotechnology, medical device, diagnostic, and dietary supplement clients in the life sciences and healthcare industries.
Marty represents innovative life sciences and technology clients in corporate transactions and governance matters.